
|Articles|March 19, 2008
John Gans stepping down from APhA
APhA's executive VP/CEO John Gans to leave APhA
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Accepts Sandoz Applications for Generic Tirzepatide
2
Amazon, Fleming Initiative Partner to Combat Antimicrobial Resistance
3
Tech-Driven Home Pharmacy Model Tackles Rural Health Crises
4
Naloxone Access Continuously Improves as Gaps Persist in Pharmacy
5































